Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T22:17:48.297Z.
Consensus retrieved: 2026-10-06T13:58:55.676Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T22:17:48.297Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fadf2323dc19255bcc42afaef1a50e536e77fb7c46cec045ed2d3efdc7ae0f8f
Forward PE Ratio (N/A) = Dated Quote Price ($4.83) / Consensus Forward EPS ($6.00)
FORWARD PE RATIO
N/A
Moolec Science S.A.
Market Cap
$3.50M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Moolec Science S.A. (MLEC) | $3.50M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | N/A |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.63M | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.65M | N/A |
| Evogene Ltd. (EVGN)vs › | $3.65M | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.28M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.25M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2027-06-30
At the dated quote price of $4.83, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2027-06-30 | $6.00 | $6.00 – $6.00 | 1 | 0.8x |
| 2028-06-30 | $30.00 | $30.00 – $30.00 | 1 | 0.2x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
